Amyris
EMERYVILLE, California, United States · Biotechnology, Manufacturing
Amyris is a global leader in renewable biological chemistry, powered by decades of experience and a world-class technology and manufacturing platform. With a proven track record of commercially successful ingredients and building blocks, Amyris has pioneered the use of living systems to convert abundant plant-based sugars into high-performance molecules. Our innovative fermentation-based products
Key facts
- Headquarters
- EMERYVILLE, California, United States
- Employees
- 995
- Industries
- Biotechnology, Manufacturing
- Status
- Private
- Website
- amyris.com
- Company page
Recent activity at Amyris
- : Amyris Appoints Dr. Sunil Chandran as Chief Technology Officer
- : Amyris Awarded Agreement from BioMaP-Consortium for $12.3 million to Develop Critical Medicines
- : AMYRIS
- : Amyris To Acquire Menolabs For Menopause Wellness Accelerating Growth Of Consumer Business
- : AMYRIS, INC.
- : AMYRIS, INC.
- : AMYRIS, INC.
- : AMYRIS, INC.
- : AMYRIS, INC.
- : AMYRIS, INC.
Amyris funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2022 | Venture | $8.0M |
| Jun 2020 | Venture | $200.0M |
| Feb 2020 | Venture | $93.7M |
| Jan 2020 | Venture | $9.8M |
| Dec 2019 | Seed | $3.9M |
Leadership
- JOHN MELO, Executive Officer, Director
- L DOERR, Director
- GEOFFREY DUYK, Director
- PHILIP EYKERMAN, Director
- CHRISTOPH GOPPELSROEDER, Director
- FRANK KUNG, Director
- CAROLE PIWNICA, Director
- STEVEN MILLS, Director
- PATRICK YANG, Director
- JAMES MCCANN, Director
- LISA QI, Director
Verified email and direct lines for Amyris’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Amyris files 4 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Amyris in the news
- Synthetic biology, once hailed as a moneymaker, meets tough times - Science | AAAS (Aug 22, 2024)
- Amyris Delivering Sustainable Alternative To Shark Squalene Adjuvant - Enabling Vaccines For All With No Sharks Killed - SynBioBeta (Oct 02, 2020)
- AMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL RESTRUCTURING TO ADVANCE STRATEGIC TRANSFORMATION - PR Newswire (Aug 09, 2023)
- Synthetic biology pioneer Amyris files for Chapter 11 bankruptcy protection - The Business Journals (Aug 10, 2023)
- Amyris and ImmunityBio Complete Joint Venture for Next Generation COVID-19 RNA Vaccine - ImmunityBio (Jan 03, 2022)
- Amyris Brand Biossance® partners With Reese Witherspoon To Accelerate Clean Beauty Movement - SynBioBeta (Apr 08, 2021)
- Leading Global Influencer Marketing Agency, MG Empower acquired by US-headquartered Amyris, Inc - MultiVu (Aug 31, 2021)
- Amyris Inc. (AMRS) Share Price Today | Amyris (AMRS) Live NSE/BSE - Value Research (Jun 17, 2022)
Companies similar to Amyris
- Exactech · Biotechnology, Manufacturing
- GVS S.p.A · Biotechnology, Manufacturing
- Encube Ethicals Pvt Ltd · Biotechnology, Manufacturing
- BASF Petronas Chemicals · Biotechnology, Manufacturing
- Laxmi Resources · Biotechnology, Manufacturing
About Amyris: questions and answers
What does Amyris do?
Amyris is a global leader in renewable biological chemistry, powered by decades of experience and a world-class technology and manufacturing platform. With a proven track record of commercially successful ingredients and building blocks, Amyris has pioneered the use of living systems to convert abundant plant-based sugars into high-performance molecules. Our innovative fermentation-based products
Where is Amyris headquartered?
Amyris is headquartered in EMERYVILLE, California, United States.
How many employees does Amyris have?
Amyris has about 995 employees.
Has Amyris raised funding?
Yes. Fundz has recorded 5 funding events for Amyris. The most recent, $8.0M, was in Sep 2022.
What is the latest news on Amyris?
On Sep 02, 2025, Amyris Appoints Dr. Sunil Chandran as Chief Technology Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy